Search Results
Found 11 results
510(k) Data Aggregation
(100 days)
B-K MEDICAL APS
Ask a specific question about this device
(168 days)
B-K MEDICAL APS
Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows: Abdominal, Cardiac, Fetal (incl Obstetrics), Intraoperative, Transurethral, Neurosurgery, Pediatrics, Transrectal, Small Parts (organ
Flex Focus 1202 supports the following scanning modes and combinations thereof: B-mode (incl.Tissue Harmonic Imaging), M-mode, PWD mode, CFM mode, Amplitude (Power) Doppler mode. The system can perform simple geometric measurements, and perform calculations in the areas of Vascular, Urology, Cardiology and OB/GYN applications. The system can guide biopsy- and puncture needles. An optional 3-D module can reconstruct a series of 2-D images into a single 3-D volume and display this on the screen. An optional Vector Flow Imaging (VFI) module: Color Flow Mapping (CFM) imaging mode with the ability to visualize both the axial and the transverse velocity. An optional RF wireless function with the ability to wireless transmit for printing and archive connectivity purpose.
Here's a breakdown of the acceptance criteria and study information for the B-K Medical Ultrasound Scanner Flex Focus 1202 (K132335), based on the provided text.
Important Note: This 510(k) summary primarily focuses on demonstrating substantial equivalence to a predicate device, rather than a de novo approval requiring extensive clinical validation of novel performance characteristics. The "device performance" in this context mainly refers to adherence to safety and performance standards already established for ultrasound systems, and the new features (RF wireless, Vector Flow Imaging) are discussed in terms of their safety and equivalence, not necessarily extensive clinical efficacy trials.
1. Table of Acceptance Criteria and Reported Device Performance
Acceptance Criteria Category | Acceptance Criteria | Reported Device Performance |
---|---|---|
Acoustic Output | Ispta ≤ 720 mW/cm² and M1 ≤ 1.9 (Track 3, non-ophthalmic); Thermal Index (TI) ≤ 6.0 | The system in the modified Flex Focus 1202 is the same as the Flex Focus 1200 and "will assure that the acoustic output always will stay below the pre-amendments upper limits i.e. Ispta ≤ 720 mW/cm² and M1 ≤ 1.9 (Track 3, non ophthalmic). The Thermal Index values are maximum 6.0, i.e. TI ≤ 6.0." It also adheres to AIUM/NEMA UD-2 and UD-3. |
Clinical Measurement Accuracy | Not explicitly stated as a numerical criterion in the provided text. Implied expectation is that accuracy is maintained consistent with previously cleared devices. | "Clinical measurements and calculations are described and accuracies are provided in the User Information." (No specific values or studies are provided in this document, but implied to be acceptable). |
Thermal, Mechanical, and Electrical Safety | Conformance to applicable medical device safety standards, including IEC 60601-1, IEC 60601-1-1, IEC 60601-1-2, IEC 60601-2-37, ISO 14971, IEC 62304, IEC 62359. Biocompatibility of patient contact materials. | "The scanner Flex Focus 1202 has been tested by a recognized Certified Body." and "has been found to conform with applicable medical device safety standards." "Cleared patient contact materials, electrical and mechanical safety are unchanged." |
RF Wireless Function (New Feature) | No interference with other devices or the ultrasound system itself. Performance to meet "actual user requirements." | "Additional testing of the RF wireless function was performed at five (5) different sites representing actual user requirements. Several test scenarios was performed and no interference was measured." |
Technological Equivalence (Overall System) | The device should demonstrate "substantial equivalence" to the identified predicate devices (K081154, K123254) in terms of intended use, modes of operation, indications for use, and technological characteristics. Only minor non-safety/efficacy impacting differences are acceptable. | The document repeatedly asserts substantial equivalence, stating the predicate device has "the same major technological characteristics as the subject device." Minor differences are limited to the optional RF wireless function. |
2. Sample Size Used for the Test Set and Data Provenance
- Acoustic Output, Thermal, Mechanical, Electrical Safety: No specific "test set" sample size in terms of patient data or image data is mentioned. The testing was likely performed on the device hardware itself following established engineering and safety standards. The provenance is internal testing and certification by a recognized body.
- RF Wireless Function: Tested at "five (5) different sites." This refers to locations, and implies device testing rather than patient data.
- Clinical Measurement Accuracy: No sample size or provenance is provided in this document; it states details are in "User Information."
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications
This type of information is generally not required or provided for a 510(k) submission seeking equivalence for an existing ultrasound system with minor modifications. The "ground truth" for the performance characteristics discussed (acoustic output, safety, electrical performance) is based on engineering measurements against recognized standards, not expert clinical interpretation of images.
4. Adjudication Method for the Test Set
Not applicable. The reported tests are primarily engineering and safety evaluations against predefined standards, not diagnostic performance assessments requiring clinical adjudication.
5. If a Multi Reader Multi Case (MRMC) Comparative Effectiveness Study Was Done
No, an MRMC comparative effectiveness study was not done. This 510(k) is aimed at demonstrating substantial equivalence for an updated ultrasound system, not to prove improved clinical effectiveness with or without AI assistance for a specific diagnostic task. The description of the device as an "Ultrasound Scanner" further indicates it's a general imaging tool, not an AI-powered diagnostic aide.
6. If a Standalone (i.e. algorithm only without human-in-the loop performance) Was Done
No, a standalone algorithm performance study was not done. This device is an ultrasound scanner, which is operated by a human. There is no indication of a standalone algorithm component that performs a diagnostic task without human interaction.
7. The Type of Ground Truth Used
- Acoustic Output, Thermal, Mechanical, Electrical Safety: Ground truth is established by adherence to international and national device safety and performance standards (e.g., AIUM/NEMA UD-2, UD-3, IEC 60601 series, ISO 14971, IEC 62304, IEC 62359). This involves physical measurements and engineering validation.
- RF Wireless Function: Ground truth is implied to be actual user requirements and freedom from interference, measured through testing scenarios.
- Clinical Measurement Accuracy: Not explicitly stated, but for a diagnostic ultrasound, this would typically involve phantoms with known dimensions or comparisons to gold standard clinical measurements. The document refers to "User Information" for these details.
8. The Sample Size for the Training Set
Not applicable. This is not a submission for an AI/CADe device that requires a training set. The device is a traditional ultrasound system.
9. How the Ground Truth for the Training Set Was Established
Not applicable, as there is no training set for this device type.
Ask a specific question about this device
(165 days)
B-K MEDICAL APS
Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows: Abdominal, Cardiac, Fetal (incl Obstetrics), Intraoperative, Transurethral, Neurosurgery, Pediatrics, Transrectal, Small Parts (organ s), Transvaginal, Peripheral vascular, Muskulo-skeletal (conventional and superficial).
Pro Focus 2202 supports the following scanning modes and combinations thereof: B-mode (incl.Tissue Harmonic Imaging), M-mode, CFM mode, Amplitude (Power) Doppler mode. The system can perform simple geometric measurements, and perform calculations in the areas of Vascular, Urology, Cardiology and OB/GYN applications. An optional ECG signal can be superimposed the ultrasound information in all modes and mode combinations. The system can guide biopsy- and puncture needles. An optional 3-D module can reconstruct a series of 2-D images into a single 3-D volume and display this on the screen. An optional Vector Flow Imaging (VFI) module: Color Flow Mapping (CFM) imaging mode with the ability to visualize both the axial and the transverse velocity. An optional RF wireless function with the ability to wireless transmit for printing and archive purpose.
The provided text pertains to a 510(k) summary for an Ultrasound Scanner Pro Focus 2202. This document details the device's technical specifications, compared to predicate devices, and an FDA clearance letter. It is a regulatory submission for a diagnostic ultrasound system, not a study evaluating an AI device's performance.
Therefore, most of the information requested in your prompt (acceptance criteria, device performance, sample sizes, expert ground truth, adjudication methods, MRMC studies, standalone performance, training set details) is not present in the provided text.
The text focuses on demonstrating substantial equivalence to previously cleared devices based on:
- Technical characteristics: Modes of operation, intended use, indications for use, and features (ECG, VFI, RF wireless).
- Safety standards compliance: Acoustic output, thermal, electrical, electromagnetic, and mechanical safety, and biocompatibility of patient contact materials.
The only "testing" mentioned that marginally relates to performance is:
"Additional testing of the RF wireless function was performed at five (5) different sites representing actual user requirements. Several test scenarios was performed and no interference was measured."
This statement is very high-level and does not provide quantified acceptance criteria or performance metrics as typically expected for proving a device meets specific criteria for accuracy, sensitivity, or specificity. It merely states that "no interference was measured," which implies a pass/fail outcome for the RF wireless function's basic operational integrity, but not diagnostic performance.
In summary, as per the provided document, I cannot fulfill your request for detailed acceptance criteria and a study proving device performance because the document does not contain this information for diagnostic performance. It is a regulatory submission for a traditional medical device, not an AI/ML-driven device with performance metrics based on clinical outcomes or expert labels.
Ask a specific question about this device
(132 days)
B-K MEDICAL APS
Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Ultrasound scanner and transducers for B, Tissue and Contrast Harmonic Imaging, M, PWD, Color Doppler, Vector Flow Imaging and combined mode imaging.
Signal analysis and display.
Guidance of biopsy needles, geometrical measurements and calculation of parameters.
Non monitoring ECG for superimposing the ultrasound information.
An optional 3-D unit can reconstruct a series of 2-D images into a single 3-D volume and display this on the screen.
An optional Vector Flow Imaging (VFI) module: Color Flow Mapping (CFM) imaging mode with the ability to visualize both the axial and the transverse velocity.
Flex Focus 1202 supports the following scanning modes and combinations thereof: B-mode (incl. Tissue Harmonic Imaging), M-mode. CFM mode. Amplitude (Power) Doppler mode
The system can perform simple geometric measurements, and perform calculations in the areas of Vascular, Urology, Cardiology and OB/GYN applications.
The system can guide biopsy- and puncture needles.
An optional 3-D unit can reconstruct a series of 2-D images into a single 3-D volume and display this on the screen.
An optional Vector Flow Imaging (VFI) module: Color Flow Mapping (CFM) imaging mode with the ability to visualize both the axial and the transverse velocity.
Transducers are linear arrays, convex arrays, phased arrays and mechanical sector.
The provided 510(k) summary for the B-K Medical Ultrasound Scanner Flex Focus 1202 focuses primarily on demonstrating substantial equivalence to predicate devices, rather than detailing a specific study to prove device performance against acceptance criteria. The document explicitly states:
"This submission introduces no new indications for use, modes, features or technologies relative to the predicate devices that require clinical testing. The clinical safety and effectiveness of ultrasound system with these characteristics are well accepted for both predicate and subject devices."
Therefore, it does not contain the information required to answer most of the questions about acceptance criteria and a specific study proving device performance. The submission relies on the established safety and effectiveness of the predicate devices and the fact that its technological characteristics are comparable.
However, based on the document, we can extract some information:
-
A table of acceptance criteria and the reported device performance
The document doesn't provide a specific table of acceptance criteria with corresponding performance results from a dedicated study. Instead, it highlights that the device's technical specifications and intended use are comparable to legally marketed predicate devices.Acceptance Criteria (Implied by Predicate Equivalence) Reported Device Performance (Implied by Comparability) Compliance with medical device regulations Device is considered substantially equivalent Acoustic output limits Ispta ≤ 720 mW/cm² and MI ≤ 1.9 (Track 3, non ophthalmic); TI ≤ 6.0 Biocompatibility of patient contact materials Complies with ISO10993-1 Thermal, mechanical, and electrical safety Tested according to IEC 60601-1 Clinical measurement accuracy Described and accuracies provided in User Guide Intended use and indications for clinical applications Comparable to predicate devices, including new "Neonatal Cephalic" application considered the same as predicates for that application. -
Sample size used for the test set and the data provenance (e.g., country of origin of the data, retrospective or prospective)
Not applicable (N/A). The submission explicitly states that "no new indications for use, modes, features or technologies" required clinical testing. Therefore, there is no specific test set of cases or related data provenance information provided. -
Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g., radiologist with 10 years of experience)
N/A. No specific test set requiring expert ground truth establishment was conducted. -
Adjudication method (e.g., 2+1, 3+1, none) for the test set
N/A. No specific test set requiring adjudication was conducted. -
If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
N/A. This device is a diagnostic ultrasound system and does not involve AI assistance for human readers in the context of an MRMC study. The submission focuses on the system's inherent diagnostic capabilities as comparable to predicate devices. -
If a standalone (i.e., algorithm only without human-in-the-loop performance) was done
N/A. This is a diagnostic ultrasound system, not an algorithm being validated in a standalone manner. Its performance is intrinsically linked to human operation. -
The type of ground truth used (expert consensus, pathology, outcomes data, etc.)
N/A. No new clinical studies were performed that would require establishing a "ground truth" for novel features or diagnostic claims. The ground truth for ultrasound systems is implicitly established through long-standing clinical practice and the validation of predicate devices. -
The sample size for the training set
N/A. As this submission describes a diagnostic ultrasound system and not an AI/ML algorithm, there is no concept of a "training set" for the device's core functionality. -
How the ground truth for the training set was established
N/A. See explanation for point 8.
Ask a specific question about this device
(131 days)
B-K MEDICAL APS
Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Ultrasound scanner and transducers for B, Tissue and Contrast Harmonic Imaging, M, PWD, CWD, Color Doppler, Vector Flow Imaging and combined mode imaging.
Signal analysis and display.
Guidance of biopsy needles, geometrical measurements and calculation of parameters.
Non monitoring ECG for superimposing the ultrasound information. An optional 3-D unit can reconstruct a series of 2-D images into a single 3-D volume and display this on the screen.
An optional Vector Flow Imaging (VFI) module: Color Flow Mapping (CFM) imaging mode with the ability to visualize both the axial and the transverse velocity.
Clinical applications:
Ultrasound Scanner Pro Focus 2202:
Fetal, Obstetrics, Abdominal, Intraoperative, Neurosurgery, Small organ, Pediatric, Neonatal Cephalic, Adult Cephalic, Cardiac, Transrectal, Transvaginal, Transurethral. Peripheral Vascular, Musculoskeletal.
Ultrasound Transducer N13C5, Type 8862: Neonatal Cephalic.
2202 supports the following scanning modes and combinations thereof:
B-mode. M-mode. CWD-mode, PWD mode and CFM mode. Tissue harmonic imaging. Contrast harmonic imaging.
An optional ECG signal can be superimposed the ultrasound information in all modes and mode combinations.
An optional 3-D unit can reconstruct a series of 2-D images into a single 3-D volume and display this on the screen.
The system can perform simple geometric measurements, and perform calculations in the areas of Vascular, Urology, Cardiology and OB/GYN applications,
The system can guide biopsy- and puncture needles.
An optional Vector Flow Imaging (VFI) module: Color Flow Mapping (CFM) imaging mode with the ability to visualize both the axial and the transverse velocity.
Here's a breakdown of the acceptance criteria and study information based on the provided text, using the requested format:
Acceptance Criteria and Device Performance
Acceptance Criteria Category | Specific Criteria | Reported Device Performance | Study Reference |
---|---|---|---|
Acoustic Output | Ispta ≤ 720 mW/cm² | The system assures acoustic output stays below pre-amendment upper limits. | N/A (General statement of compliance) |
MI ≤ 1.9 (Track 3, non-ophthalmic) | The system assures acoustic output stays below pre-amendment upper limits. | N/A (General statement of compliance) | |
Thermal Index (TI) ≤ 6.0 | Maximum Thermal Index values are 6.0. | N/A (General statement of compliance) | |
Clinical Measurement Accuracy | Described and accuracies provided in User Guide. | Clinical measurements and calculations are described, and accuracies are provided with the User Guide. | User Guide (assumed to be external document) |
Safety (Thermal, Mechanical, Electrical) | Compliance with IEC 60601-1. | The scanner 2202 has been tested by a recognized, certified body according to IEC 60601-1. | IEC 60601-1 (stated as met) |
Acoustic Output Reporting | According to "Information for Manufacturers Seeking Clearance of Diagnostic Ultrasound Systems and Transducers, FDA, CDRH, September 30, 2008" and "Acoustic Output Measurement Standard for Diagnostic Ultrasound Equipment" (AIUM 1998). | Acoustic Output Reporting is made according to the specified standards (FDA 2008 and AIUM 1998). | FDA 2008, AIUM 1998 (stated as met) |
Intended Use & Indications for Use | Comparable to predicate devices for all listed clinical applications and modes. | Stated as "Comparable" to predicate devices (ZONARE ZS3, Philips CX50, Toshiba Aplio systems) for all indications, including the new Neonatal Cephalic application. No new indications for use, modes, features, or technologies that require clinical testing are introduced relative to the predicate devices. | Predicate Device Comparison Table (Sections 2, 7 & 8) |
Study Information
The provided document describes a 510(k) Pre-market Notification for an Ultrasound Scanner (Pro Focus 2202) and a specific transducer (N13C5 Type 8862). This submission primarily focuses on demonstrating substantial equivalence to existing legally marketed predicate devices, rather than conducting new clinical studies to prove device performance against specific novel acceptance criteria.
Therefore, many of the requested study details (e.g., sample size for test/training sets, number of experts for ground truth, adjudication methods, MRMC studies) are not applicable (N/A) because the core of this submission is a comparison to established devices and their existing performance and safety profiles.
Here's a breakdown of what can be gleaned:
-
Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective):
- N/A. The submission states: "This submission introduces no new indications for use, modes, features or technologies relative to the predicate devices that require clinical testing." This indicates that no new clinical test sets were generated or utilized to prove performance in the traditional sense of a clinical trial for a novel device. The "test set" in this context is implicitly the historical data and established clinical performance of the predicate devices.
-
Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience):
- N/A. As no new explicit clinical test set was used for this submission, there was no need for a new "ground truth" establishment by experts specifically for this device's performance claims. The substantial equivalence relies on the established ground truth and clinical acceptance of the predicate devices.
-
Adjudication method (e.g. 2+1, 3+1, none) for the test set:
- N/A. No new clinical test set requiring adjudication was performed as part of this substantial equivalence submission.
-
If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:
- No. The device is a diagnostic ultrasound system. There is no mention of AI or machine learning components, nor any MRMC study.
-
If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:
- No. This is a diagnostic ultrasound system with human-in-the-loop operation. No standalone algorithm performance is reported.
-
The type of ground truth used (expert consensus, pathology, outcomes data, etc):
- N/A. For this substantial equivalence submission, the "ground truth" for the device's acceptable performance and safety is implicitly tied to the established and accepted clinical performance, safety profiles, and regulatory clearances of the predicate devices. New ground truth for a novel claim was not established as part of this submission.
-
The sample size for the training set:
- N/A. This is not an AI/ML device, so there is no training set in that context.
-
How the ground truth for the training set was established:
- N/A. As above, not an AI/ML device.
Ask a specific question about this device
(118 days)
B-K MEDICAL APS
Diagnostic ultrasound imaging or fluid flow analysis of the human body.
Ultrasound scanner and transducers for B, Tissue and Contrast Harmonic Imaging, M, PWD, CWD, Color Doppler, Vector Flow Imaging and combined mode imaging.
Signal analysis and display.
Guidance of biopsy needles, geometrical measurements and calculation of parameters.
Non monitoring ECG for superimposing the ultrasound information.
An optional 3-D unit can reconstruct a series of 2-D images into a single 3-D volume and display this on the screen.
An optional Vector Flow Imaging (VFI) module: Color Flow Mapping (CFM) imaging mode with the ability to visualize both the axial and the transverse velocity.
Clinical applications: Abdominal, Cardiac, Fetal, Intraoperative, Neurosurgery, Obstetrics, Transrectal, Small organs, Transvaginal, Musculoskeletal.
Flex Focus 1202 supports the following scanning modes and combinations thereof: B-mode (incl.Tissue Harmonic Imaging), M-mode, PWD mode, CFM mode, Amplitude (Power) Doppler mode.
The system can perform simple geometric measurements, and perform calculations in the areas of Vascular, Urology, Cardiology and OB/GYN applications.
The system can guide biopsy- and puncture needles.
An optional 3-D module can reconstruct a series of 2-D images into a single 3-D volume and display this on the screen.
An optional Vector Flow Imaging (VFI) module: Color Flow Mapping (CFM) imaging mode with the ability to visualize both the axial and the transverse velocity.
Transducers are linear arrays, convex arrays, phased arrays and mechanical sector. The patient contact materials are biocompatible.
All transducers used together with Flex Focus 1202 are Track 3 transducers.
The provided text describes a 510(k) summary for the B-K Medical Ultrasound Scanner Flex Focus 1202. This document focuses on demonstrating substantial equivalence to predicate devices, rather than presenting a study to prove a device meets specific clinical performance acceptance criteria.
The information primarily discusses the device's technical specifications, modes of operation, intended use, indications for use, and safety aspects (thermal, mechanical, electrical, and acoustic output). It leverages existing standards and prior clearances for similar devices.
Therefore, many of the requested details regarding acceptance criteria for device performance and an accompanying study or analysis are not present in the provided text.
Here's a breakdown of what can and cannot be extracted:
1. A table of acceptance criteria and the reported device performance
The document does not specify quantitative clinical performance acceptance criteria for the device in terms of accuracy, sensitivity, or specificity. Instead, it relies on technical and safety compliance.
Acceptance Criteria (Stated or Implied) | Reported Device Performance / Compliance |
---|---|
Acoustic Output: | |
Ispta ≤ 720 mW/cm² | Stated to stay below this limit |
MI ≤ 1.9 (Track 3, non-ophthalmic) | Stated to stay below this limit |
TI ≤ 6.0 | Maximum 6.0 |
Clinical Measurement Accuracy: | Described and accuracies provided in User Information (details not provided in this document) |
Safety: | |
Thermal, mechanical, electrical safety | Tested by a recognized Certified Body |
Acoustic Output Reporting: | Made according to FDA standards |
Modes of Operation: | B, M, PWD, CFM, Tissue Harmonic Imaging, and combinations (including optional VFI module) |
Intended Use: | Diagnostic ultrasound imaging or fluid flow analysis of the human body |
Indications For Use: | Abdominal, Cardiac, Fetal, Intraoperative, Transurethral, Neurosurgery, Pediatrics, Transrectal, Small Parts, Transvaginal, Peripheral vascular, Musculoskeletal |
Biocompatibility: | Patient contact materials are biocompatible |
Substantial Equivalence: | Determined by FDA to be substantially equivalent to predicate devices K081154 and K100919 |
No information is provided for the following points related to a performance study:
- 2. Sample size used for the test set and the data provenance: Not applicable as no clinical performance study is detailed.
- 3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts: Not applicable.
- 4. Adjudication method (e.g. 2+1, 3+1, none) for the test set: Not applicable.
- 5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance: Not applicable. This device is an ultrasound scanner, not an AI-assisted diagnostic tool.
- 6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done: Not applicable.
- 7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.): Not applicable for clinical performance as described in the prompt. For technical and safety aspects, the ground truth is often established by adherence to recognized standards and validated testing procedures.
- 8. The sample size for the training set: Not applicable as it's not a machine learning/AI device.
- 9. How the ground truth for the training set was established: Not applicable.
In summary, this document is a regulatory submission for premarket clearance (510(k)) based on substantial equivalence, not a clinical trial report detailing performance criteria and a study to meet them. The "acceptance criteria" here largely pertain to technical specifications, safety limits, and intended/indicated uses matching those of previously cleared devices, rather than quantitative clinical efficacy metrics.
Ask a specific question about this device
(623 days)
B-K MEDICAL APS
Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows: Abdominal, Cardiac, Fetal (incl Obstetrics), Intraoperative, Transurethral, Neurosurgery, Pediatrics, Transrectal, Small Parts (organ s), Transvaginal, Peripheral vascular, Muskulo-skeletal (conventional and superficial)
Pro Focus 2202 supports the following scanning modes and combinations thereof: B-mode (incl.Tissue Harmonic Imaging), M-mode, PWD mode, CFM mode, Amplitude (Power) Doppler mode. The system can perform simple geometric measurements, and perform calculations in the areas of Vascular, Urology, Cardiology and OB/GYN applications. The system can guide biopsy- and puncture needles. An optional ECG signal can be superimposed the ultrasound information in all modes and mode combinations. An optional 3-D module can reconstruct a series of 2-D images into a single 3-D volume and display this on the screen. An optional Vector Flow Imaging (VFI) module: Color Flow Mapping (CFM) imaging mode with the ability to visualize both the axial and the transverse velocity. Transducers are linear arrays, convex arrays, phased arrays and mechanical sector. The patient contact materials are biocompatible. All transducers used together with Pro Focus 2202 are Track 3 transducers.
The provided document is a 510(k) Summary for an Ultrasound Scanner Pro Focus 2202. It primarily focuses on demonstrating substantial equivalence to a predicate device and does not contain information about acceptance criteria or a specific study proving the device meets acceptance criteria in the way a clinical performance study would.
Instead, the document details the device's technical specifications, intended use, and substantial equivalence to a previously cleared device (K043524). The "acceptance criteria" discussed are largely related to regulatory compliance and safety standards, rather than clinical performance metrics for a novel algorithm or feature.
Here's a breakdown of the available information based on your requested points:
1. Table of Acceptance Criteria and Reported Device Performance
Based on the document, the "acceptance criteria" are primarily related to safety, acoustic output, and functional equivalence to the predicate device. There isn't a table of clinical performance metrics with pre-defined acceptance thresholds and observed values in the provided text. The document states:
"Clinical measurements and calculations are described and accuracies are provided in the User Information."
This suggests that accuracy specifications for measurements are available but not provided within this 510(k) summary. The document focuses on regulatory compliance:
Acceptance Criteria Category | Reported Device Performance/Compliance |
---|---|
Acoustic Output Limits | Acoustic output always stays below pre-amendment upper limits: Ispta ≤ 720 mW/cm² and MI ≤ 1.9 (Track 3, non-ophthalmic). Thermal Index values: TI ≤ 6.0 |
Acoustic Output Reporting | Made according to "Information for Manufacturers Seeking Clearance of Diagnostic Ultrasound Systems and Transducers, FDA, CDRH, September 9, 2008" |
Thermal, Mechanical, Electrical Safety | Tested by a recognized Certified Body. |
Biocompatibility | Patient contact materials are biocompatible. |
Functional Equivalence | Same major technological characteristics as predicate K043524. Minor difference: Optional Vector Flow Imaging (VFI) module. |
Clinical Measurement Accuracy | "Described and accuracies are provided in the User Information" (details not in this document). |
2. Sample Size Used for the Test Set and Data Provenance
Not applicable as this document does not describe a clinical performance study with a distinct "test set" in the context of algorithm evaluation. The document discusses regulatory validation against predicate devices and safety standards.
3. Number of Experts Used to Establish Ground Truth and Qualifications
Not applicable. Ground truth, in the context of clinical studies, is not mentioned for this submission. The "ground truth" for regulatory clearance is essentially compliance with standards and equivalence to a predicate device.
4. Adjudication Method
Not applicable for a clinical performance study.
5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study
No. This document does not mention an MRMC study or any comparison of human readers with vs. without AI assistance. The device is a diagnostic ultrasound system, and the AI component (if any) is not explicitly detailed as a reader assistance tool from this summary. The "Vector Flow Imaging (VFI)" is a new imaging mode, not an AI interpretation aid.
6. Standalone (Algorithm Only) Performance Study
No. The document describes a diagnostic ultrasound system, not a standalone algorithm. The VFI module is an integrated imaging mode.
7. Type of Ground Truth Used
Not applicable for a clinical performance study. For regulatory purposes, the "ground truth" is that the device meets safety standards and is substantially equivalent to a previously cleared device.
8. Sample Size for the Training Set
Not applicable. This document does not describe the development or training of a specific algorithm that would require a "training set."
9. How the Ground Truth for the Training Set Was Established
Not applicable.
Ask a specific question about this device
(53 days)
B-K MEDICAL APS
Needle guide(s) provides guidance for needles or other interventional devices during an ultrasound-guided procedure. It positions the needle relative to the transducer, so that the needle image is in a specified position in the ultrasound image during procedures. that require precise needle placement or biopsy.
The BK Medical Needle Guides described are designed to be used with BK Medical' Ultrasound system to provide alignment with an ultrasound intra-operative transducer, in order to guide a needle (biopsy device, or other interventional device) in relation to the ultrasound image. The components for the Needle Guides are all single use disposable, and delivered sterile. Note! The needle guides are delivered without needles.
The provided text describes a 510(k) premarket notification for a medical device (Needle Guide for BK Medical ultrasound transducers) and its comparison to a predicate device. The information is presented in the context of demonstrating substantial equivalence, not a study proving specific performance metrics against acceptance criteria.
Specifically, the document does not contain a study with acceptance criteria and reported device performance as typically understood for a detailed clinical or analytical validation study for an AI/ML device. The provided text is a summary of a regulatory submission (510(k)) that focuses on showing the new device is "substantially equivalent" to an already approved device. This process primarily relies on comparing technological characteristics and intended use.
Therefore, many of your requested points cannot be answered from the provided text. I will indicate where the information is missing or not applicable based on the nature of the document.
1. Table of Acceptance Criteria and Reported Device Performance
This table cannot be fully generated as the document does not specify formal acceptance criteria for device performance or report specific performance metrics in a study. The comparison table focuses on technological characteristics and intended use for substantial equivalence.
Acceptance Criteria | Reported Device Performance (from text) |
---|---|
Formal Acceptance Criteria (e.g., accuracy, precision for needle guidance) | Not provided in the document. The document aims to demonstrate substantial equivalence, not to quantify specific performance against defined metrics. |
Intended Use Equivalence: "Needle guide provides guidance for needles or other interventional devices during an ultrasound-guided procedure. It positions the needle relative to the transducer, so that the needle image is in a specified position in the ultrasound image during procedures that require precise needle placement or biopsy." | Met: The "Conclusion" states, "The needle guides in this application have same intended use and the same characteristics as the predicate device." |
Technological Characteristics Equivalence: (e.g., Needle Guide angle, Pre-sterilized, Removable options, For use with variety of Needles, Materials, Single Use/Disposable, Device Description) | Met: The table in the "510(k) Summary continue" section explicitly compares these characteristics, showing them to be the same or similar, leading to the conclusion of substantial equivalence. |
2. Sample size used for the test set and the data provenance
- Sample Size: Not applicable. This document is not a report of a performance study that uses a test set of data. It is a regulatory submission for substantial equivalence.
- Data Provenance: Not applicable.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts
- Not applicable. No ground truth establishment from experts for a test set is described in this regulatory submission.
4. Adjudication method for the test set
- Not applicable. No adjudication method for a test set is described.
5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, if so, what was the effect size of how much human readers improve with AI vs without AI assistance
- No, an MRMC comparative effectiveness study was not done. This device is a physical needle guide, not an AI-assisted diagnostic tool.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
- No, a standalone algorithm performance study was not done. This device is a physical needle guide.
7. The type of ground truth used
- Not applicable. No ground truth in the context of a performance study is mentioned. The "ground truth" for the 510(k) submission is the existence and characteristics of the legally marketed predicate device.
8. The sample size for the training set
- Not applicable. This device is not an AI/ML algorithm that requires a training set.
9. How the ground truth for the training set was established
- Not applicable.
Ask a specific question about this device
(71 days)
B-K MEDICAL APS
Purpose: Performing ultrasound guided biopsies of the prostate.
Indications for Use: Performing ultrasound guided biopsies of the prostate
The biopsy guides are designed to be used with B-K Medical's ultrasound systems to guide needles for taking biopsies of the prostate and similar soft tissue. The biopsy guides are fixed to the ultrasonic probe, and provide a predetermined path for a biopsy needle. The biopsy guides are similar to previously used biopsy guides delivered non sterile. The new biopsy guides are delivered sterile.
This appears to be a 510(k) summary and FDA clearance letter for a medical device, specifically biopsy needle guides. This type of document is about regulatory clearance based on substantial equivalence to a predicate device, not typically a detailed study proving performance against acceptance criteria in the way an AI/software as a medical device (SaMD) study would.
Therefore, many of the requested categories (e.g., sample size for test set, number of experts, adjudication method, MRMC study, standalone performance, training set, ground truth for training set) are not applicable to this type of submission. This submission primarily focuses on comparing the technological characteristics of the new device to a legally marketed predicate device to demonstrate substantial equivalence, particularly regarding a change in delivery (from non-sterile to sterile).
However, I can extract information related to the device's characteristics and intended use, and frame the "acceptance criteria" based on the comparison to the predicate device.
1. Table of Acceptance Criteria and Reported Device Performance
Acceptance Criteria Category | Description (Based on Predicate Device) | Reported Device Performance |
---|---|---|
Intended Use | Performing ultrasound-guided biopsies of the prostate. | The subject device performs ultrasound-guided biopsies of the prostate. |
Target Organ | Prostate and similar soft tissue. | Designed for biopsies of the prostate and similar soft tissue. |
Mechanism of Action | Fixed to ultrasonic probe, provides a predetermined path for a biopsy needle. | Functions by being fixed to the ultrasonic probe and providing a predetermined path for a biopsy needle. |
Sterility | Not explicitly stated as a separate criterion for the predicate in this text, but the predicate was "delivered non sterile." | The new biopsy guides are "delivered sterile." (This is the primary difference and a key characteristic.) |
Compatibility | Used with B-K Medical's ultrasound systems. | Compatible with B-K Medical's ultrasound systems. |
Patient Population | Adult patients. | Intended for adult patients. |
Environment of Use | Physician office or hospital environment. | For use by medical professionals in a physician office or hospital environment. |
Technological Characteristics | Same major technological characteristics as the predicate device (e.g., materials, design, dimensions for guiding needles) with the exception of sterility. | The device maintains the "same major technological characteristics as the subject device" compared to the predicate, with the key difference being sterility. |
Study Proving Device Meets Acceptance Criteria:
The document describes a 510(k) premarket notification submission. The "study" in this context is a comparison of the subject device (new biopsy guides) to a legally marketed predicate device (Targetscan biopsy kit, Targetscan biopsy needle guide - K073399) to establish substantial equivalence.
The core of the "proof" is the declaration that: "The predicate device has the same major technological characteristics as the subject device, see comparison below." The only mentioned difference is that the new biopsy guides are delivered sterile, whereas the predicate was delivered non sterile. This sterility change would typically involve validation studies (e.g., sterilization validation) which are part of the overall submission but not detailed in this summary.
Further Requested Information (Not Applicable to this type of 510(k) Summary):
2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)
- N/A. This is a substantial equivalence submission for a physical medical device, not an AI/SaMD performance study using a test set of data.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)
- N/A. Ground truth for image interpretation or diagnosis is not relevant to this device's regulatory review.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set
- N/A. Not an AI/SaMD performance study.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
- N/A. This device is a biopsy guide, not an AI/software product that assists human readers.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
- N/A. This device is a physical medical device, not an algorithm.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)
- N/A. Ground truth in the context of diagnostic accuracy is not relevant here. The "ground truth" for this submission is that the predicate device is legally marketed and safe/effective for its intended use, and the new device is functionally identical with an added sterility benefit.
8. The sample size for the training set
- N/A. Not an AI/SaMD.
9. How the ground truth for the training set was established
- N/A. Not an AI/SaMD.
Ask a specific question about this device
(30 days)
B-K MEDICAL APS
Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows: Abdominal, Cardiac, Fetal (incl Obstetrics), Intraoperative, Transurethral, Neurosurgery, Pediatrics, Transrectal, Small Parts (organs), Transvaginal, Peripheral vascular, Musculo-skeletal.
Flex Focus 1202 supports the following scanning modes and combinations thereof: B-mode (incl.Tissue Harmonic Imaging), M-mode, PWD mode, CFM mode, Amplitude (Power) Doppler mode. The system can perform simple geometric measurements, and perform calculations in the areas of Vascular, Urology, Cardiology and OB/GYN applications. The system can guide biopsy- and puncture needles. An optional 3-D unit can reconstruct a series of 2-D images into a single 3-D volume and display this on the screen.
Here's an analysis of the provided text regarding acceptance criteria and the study:
The provided 510(k) summary for the B-K Medical Ultrasound Scanner Flex Focus 1202 (K081154) does not contain information about a diagnostic study for AI/algorithm performance against acceptance criteria.
Instead, this submission is for a traditional ultrasound system and focuses on demonstrating substantial equivalence to a predicate device (B-K Medical Ultrasound Scanner Pro Focus 2202, K043524) based on technological characteristics and intended use. The "acceptance criteria" mentioned implicitly refer to safety and performance standards for diagnostic ultrasound systems as per FDA guidelines at the time (e.g., "Information for Manufacturers Seeking Clearance of Diagnostic Ultrasound Systems and Transducers, FDA, CDRH, September 30, 1997").
Let's break down the information available and what is missing, based on your requested categories:
1. Table of Acceptance Criteria and Reported Device Performance
Since this is not a submission for an AI/CAD/algorithmic device, there are no specific diagnostic performance metrics (e.g., sensitivity, specificity, AUC) or acceptance criteria (e.g., "sensitivity must be >X%") against which the device performance is measured in a clinical study.
The primary "performance" discussed relates to technological characteristics and acoustic output safety.
Feature/Criterion | Acceptance Criteria (Implied by Predicate Equivalence & Standards) | Reported Device Performance (Flex Focus 1202) |
---|---|---|
Modes of Operation | Must support B, M, PWD, CFM (Color Flow Mapping/Color Doppler and Amplitude Doppler), and combinations, including Tissue Harmonic Imaging. (Based on predicate device Pro Focus 2202) | Supports B-mode (incl. Tissue Harmonic Imaging), M-mode, PWD mode, CFM mode, Amplitude (Power) Doppler mode. The table on page 2 explicitly lists these modes for various clinical applications, indicating previous FDA clearance (P) for these modes and applications. |
Clinical Applications | Must support Abdominal, Cardiac, Fetal (incl Obstetrics), Intraoperative, Transurethral, Neurosurgery, Pediatrics, Transrectal, Small Parts (organs), Transvaginal, Peripheral vascular, Musculo-skeletal. (Based on predicate device Pro Focus 2202) | Supports all listed clinical applications. The table on page 2 explicitly states "1202 intended uses are contained within 2202-intended uses" and details P-status for all these clinical applications and modes. |
Simple Geometric Measurements & Calculations | Ability to perform simple geometric measurements and calculations in areas like Vascular, Urology, Cardiology, OB/GYN. (Standard for diagnostic ultrasound) | The system can perform simple geometric measurements, and perform calculations in the areas of Vascular, Urology, Cardiology and OB/GYN applications. Clinical measurement accuracy is stated to be described in the User Guide. |
Biopsy/Puncture Guidance | Ability to guide biopsy- and puncture needles. (Standard for diagnostic ultrasound) | The system can guide biopsy- and puncture needles. |
3-D Reconstruction (Optional) | Ability to reconstruct 2-D images into a 3-D volume and display. (Optional feature, likely assessed for function) | An optional 3-D unit can reconstruct a series of 2-D images into a single 3-D volume and display this on the screen. |
Transducers | Must use linear arrays, convex arrays, phased arrays, and mechanical sector transducers with biocompatible patient contact materials. Track 3 transducers. (Standard for safety/performance) | Transducers are linear arrays, convex arrays, phased arrays and mechanical sector. The patient contact materials are biocompatible. All transducers used together with Flex Focus 1202 are Track 3 transducers. Specific transducers (1850, 8661, 8662, 8811, 8820e, 4.00) are listed as cleared with the system. |
Acoustic Output Safety | Acoustic output must stay below pre-amendments upper limits; Ispta ≤ 720 mW/cm², MI ≤ 1.9 (Track 3, non-ophthalmic), TI ≤ 6.0. (FDA standard "Information for Manufacturers...") | The system controlling the Acoustic Output in Flex Focus 1202 is the same as the system in Pro Focus 2200. The system will assure that the acoustic output always will stay below the pre-amendments upper limits i.e. Ispta ≤ 720 mW/cm² and MI ≤ 1.9 (Track 3, non ophthalmic). The Thermal Index values are maximum 6.0, i.e. TI ≤ 6.0. |
Safety Testing (Thermal, Mechanical, Electrical) | Must be tested by a recognized Certified Body to ensure safety. (Regulatory requirement) | The scanner Flex Focus 1202 has been tested by a recognized Certified Body. |
Substantial Equivalence | The device must have the same intended use and similar technological characteristics to a legally marketed predicate device, or differences must not raise new questions of safety/effectiveness. | The device's intended uses are contained within the predicate device's (Pro Focus 2202, K043524). Major technological characteristics are the same. Minor differences (modified scanconverter, transmitter, beamformer, mechanical outline) are considered not to raise new questions of safety or effectiveness. |
2. Sample Size Used for the Test Set and the Data Provenance
This information is not provided as there is no diagnostic study with a "test set" in the context of an AI/algorithm. The submission is for an ultrasound system, and its "performance" is primarily demonstrated through engineering specifications, comparison to a predicate device, and compliance with general safety and performance standards for ultrasound equipment.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts
This information is not applicable/not provided. There is no "test set" requiring ground truth established by experts for a diagnostic algorithm in this submission.
4. Adjudication Method for the Test Set
This information is not applicable/not provided. There is no "test set" or adjudication process described as part of this traditional ultrasound system 510(k).
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
No, a Multi-Reader Multi-Case (MRMC) comparative effectiveness study was not done. This device is a standalone ultrasound system, not an AI or CAD (Computer-Aided Detection/Diagnosis) system designed to assist human readers.
6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done
This information is not applicable/not provided. The device itself is an ultrasound imaging system, not a standalone diagnostic algorithm.
7. The Type of Ground Truth Used (Expert Consensus, Pathology, Outcomes Data, etc.)
This information is not applicable/not provided. "Ground truth" in the context of a diagnostic dataset is not discussed here, as this is a submission for an ultrasound imaging device itself, not an AI/algorithmic device requiring such a validation.
8. The Sample Size for the Training Set
This information is not applicable/not provided. There is no "training set" for an AI algorithm discussed in this submission.
9. How the Ground Truth for the Training Set was Established
This information is not applicable/not provided. There is no "training set" or establishment of "ground truth" for it in this submission.
In summary:
The provided document is a 510(k) summary for a traditional diagnostic ultrasound system. It demonstrates substantial equivalence to a predicate device by comparing intended uses and technological characteristics, and by declaring compliance with relevant safety and performance standards for ultrasound (e.g., acoustic output limits). It does not involve any AI/CAD algorithms, and therefore, the specific types of studies, acceptance criteria, and ground truth methodologies relevant to AI/algorithmic performance are not present in this submission.
Ask a specific question about this device
Page 1 of 2